Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin

被引：8

作者：

Betriu, C ^{[1
]}

Culebras, E ^{[1
]}

Redondo, M ^{[1
]}

Rodríguez-Avial, I ^{[1
]}

Gómez, M ^{[1
]}

Boloix, A ^{[1
]}

Picazo, JJ ^{[1
]}

机构：

[1] Hosp Clin San Carlos, Dept Clin Microbiol, Madrid, Spain

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 50卷 / 03期

关键词：

D O I：

10.1093/jac/dkf128

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：436 / U11

页数：3

共 6 条

[1] In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes:: Influences of resistance mechanisms and methodological factors [J].

Bemer-Melchior, P ;

Juvin, ME ;

Tassin, S ;

Bryskier, A ;

Schito, GC ;

Drugeon, HB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :2999-3002

[2] In vitro activity of ketolides telithromycin and HMR 3004 against Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility [J].

Giovanetti, E ;

Montanari, MP ;

Marchetti, F ;

Varaldo, PE .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :905-908

[3] In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species [J].

Jalava, J ;

Kataja, J ;

Seppälä, H ;

Huovinen, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) :789-793

[4]

National Committee for Clinical Laboratory Standards, 1999, M100S9 NCCLS

[5]

SEPPALA H, 1994, J CLIN MICROBIOL, V32, P1945

[6] Detection of erythromycin-resistant determinants by PCR [J].

Sutcliffe, J ;

Grebe, T ;

TaitKamradt, A ;

Wondrack, L .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (11) :2562-2566

← 1 →